Antimicrobial activity of WCK 4282 (high-dose cefepime-tazobactam) tested against Gram-negative organisms from medical centres located in Europe and the Asia-Pacific region

Mapping Intimacies ◽

10.26226/morressier.56d6be79d462b80296c97c5d ◽

2016 ◽

Author(s):

Helio Sader

Keyword(s):

Antimicrobial Activity ◽

Asia Pacific ◽

High Dose ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Gram Negative Organisms

Download Full-text

Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 14,850 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)

10.26226/morressier.56d6be7ad462b80296c97cbf ◽

2016 ◽

Author(s):

Helio Sader

Keyword(s):

Antimicrobial Activity ◽

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Gram Negative Organisms

Download Full-text

Antimicrobial activity among gram-positive and gram-negative organisms collected from the Asia-Pacific region as part of the Tigecycline Evaluation and Surveillance Trial: Comparison of 2015 results with previous years

Diagnostic Microbiology and Infectious Disease ◽

10.1016/j.diagmicrobio.2017.08.014 ◽

2017 ◽

Vol 89 (4) ◽

pp. 314-323 ◽

Author(s):

Qiwen Yang ◽

Ying-Chun Xu ◽

Pattarachai Kiratisin ◽

Michael J. Dowzicky

Keyword(s):

Antimicrobial Activity ◽

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Positive ◽

Gram Negative ◽

Gram Negative Organisms

Download Full-text

Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013–2014)

Diagnostic Microbiology and Infectious Disease ◽

10.1016/j.diagmicrobio.2017.02.020 ◽

2017 ◽

Vol 88 (2) ◽

pp. 177-183 ◽

Author(s):

M.A. Pfaller ◽

R.K. Flamm ◽

L.R. Duncan ◽

R.E. Mendes ◽

R.N. Jones ◽

...

Keyword(s):

Antimicrobial Activity ◽

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Gram Negative Organisms

Download Full-text

Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2012.09.007 ◽

2013 ◽

Vol 41 (1) ◽

pp. 47-51 ◽

Author(s):

Pattarachai Kiratisin ◽

Rebecca A. Keel ◽

David P. Nicolau

Keyword(s):

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Gram Negative Organisms

Download Full-text

Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program—Asia-Pacific Region

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2010.10.024 ◽

2011 ◽

Vol 37 (3) ◽

pp. 225-229 ◽

Author(s):

Jason A. Roberts ◽

Andrea Kwa ◽

Preecha Montakantikul ◽

Charles Gomersall ◽

Joseph L. Kuti ◽

...

Keyword(s):

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Intravenous Antibiotics ◽

Gram Negative Organisms

Download Full-text

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

International Journal of Antimicrobial Agents ◽

10.1016/s0924-8579(12)70008-0 ◽

2012 ◽

Vol 40 ◽

pp. S37-S43 ◽

Author(s):

Po-Liang Lu ◽

Yung-Ching Liu ◽

Han-Siong Toh ◽

Yu-Lin Lee ◽

Yuag-Meng Liu ◽

...

Keyword(s):

Urinary Tract ◽

Antimicrobial Resistance ◽

Antimicrobial Susceptibility ◽

Asia Pacific ◽

Gram Negative Bacteria ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Tract Infections ◽

Susceptibility Profiles

Download Full-text

Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2020.105883 ◽

2020 ◽

Vol 55 (3) ◽

pp. 105883 ◽

Author(s):

Shu-Chen Kuo ◽

Chun-Eng Liu ◽

Po-Liang Lu ◽

Yao-Shen Chen ◽

Min-Chi Lu ◽

...

Keyword(s):

Respiratory Tract ◽

Lower Respiratory Tract ◽

Respiratory Tract Infections ◽

Asia Pacific ◽

Pacific Region ◽

Lower Respiratory Tract Infections ◽

Asia Pacific Region ◽

Gram Negative ◽

Tract Infections

Download Full-text

Increasing extended-spectrum β-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: Data from the Smart Study 2002–2006

Journal of Infection ◽

10.1016/j.jinf.2009.06.003 ◽

2009 ◽

Vol 59 (2) ◽

pp. 95-103 ◽

Author(s):

Wen-Chien Ko ◽

Po-Ren Hsueh

Keyword(s):

Quinolone Resistance ◽

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

Extended Spectrum ◽

Smart Study ◽

Region Data ◽

Abdominal Infections

Download Full-text

Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004–2010

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2012.02.018 ◽

2012 ◽

Vol 39 (6) ◽

pp. 490-495 ◽

Author(s):

Stephen P. Hawser ◽

Samuel K. Bouchillon ◽

Meredith Hackel ◽

Minjun Chen ◽

Eui-Chong Kim

Keyword(s):

Vitro Activity ◽

Asia Pacific ◽

Pacific Region ◽

In Vitro Activity ◽

Asia Pacific Region ◽

Gram Positive ◽

Gram Negative ◽

Download Full-text

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Antimicrobial Agents and Chemotherapy ◽

10.1128/aac.00426-09 ◽

2009 ◽

Vol 53 (8) ◽

pp. 3280-3284 ◽

Author(s):

Stephen P. Hawser ◽

Samuel K. Bouchillon ◽

Daryl J. Hoban ◽

Robert E. Badal ◽

Po-Ren Hsueh ◽

...

Keyword(s):

Klebsiella Pneumoniae ◽

Klebsiella Oxytoca ◽

Asia Pacific ◽

Pacific Region ◽

Asia Pacific Region ◽

Gram Negative ◽

E Coli ◽

Extended Spectrum ◽

Region Data ◽

Abdominal Infections

ABSTRACT Of 3,004 gram-negative bacilli collected from intra-abdominal infections in the Asia-Pacific region during 2007, 42.2% and 35.8% of Escherichia coli and Klebsiella spp., respectively, were extended-spectrum β-lactamase (ESBL) positive. Moreover ESBL rates in India for E. coli, Klebsiella pneumoniae, and Klebsiella oxytoca were 79.0%, 69.4%, and 100%, respectively. ESBL-positive E. coli rates were also relatively high in China (55.0%) and Thailand (50.8%). Ertapenem and imipenem were the most active drugs tested, inhibiting over 90% of all species, including ESBL-positive isolates with the exception of Pseudomonas aeruginosa isolates (<90% susceptible to all study drugs) and ESBL-positive Klebsiella pneumoniae isolates (<90% susceptible to all study drugs except imipenem). Quinolones achieved 90% inhibition levels only against ESBL-negative K. pneumoniae and ESBL-negative K. oxytoca. A decline in ampicillin-sulbactam activity was noted, with only 34.5% of all Enterobacteriaceae inhibited in this study.

Download Full-text